(2S,3S,5S,6R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-7-((1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-2,6-dimethyl-heptanal | 135708-92-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: (2S,3S,5S,6R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-7-((1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-2,6-dimethyl-heptanal
• 英文别名: (2S,3S,5S,6R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-7-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,6-dimethylheptanal
• CAS: 135708-92-8
• 化学式: C₂₈H₅₈O₅Si₂
• 分子量: 530.937
• InChiKey: WNUYCDGXDRDDOE-KNTYIVJVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.19
• 重原子数：
  35
• 可旋转键数：
  14
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.96
• 拓扑面积：
  65
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (2S,3S,5S,6R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-7-((1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-2,6-dimethyl-heptanal 、 2-(三苯基膦亚基)丙酸甲酯 以 甲苯 为溶剂， 反应 36.0h， 以64%的产率得到(E)-(4R,5S,7S,8R)-5,7-Bis-(tert-butyl-dimethyl-silanyloxy)-9-((1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-2,4,8-trimethyl-non-2-enoic acid methyl ester
  参考文献：
  名称：

  Synthetic studies toward rapamycin: a solution to a problem in chirality merger through use of the Ireland reaction

  摘要：

  A program directed toward a total synthesis of rapamycin is described. This paper reports the synthesis of enoate 36, a fragment that would correspond to carbons 28-49 of rapamycin. The two building blocks required to reach 36 were allylic alcohol 5 and acid 6. The former was obtained in a straightforward way from D-(+)-glucose. The route passed through a 5,6-methylene derivative (see structure 12) that underwent Ferrier transformation to the hydroxycyclohexanone derivative 13. The acid 6 was built from aldehyde 15. An addition reaction of allyltrimethylsilane to 15 and a subsequent addition of crotylboronate 18 to aldehyde 17 were the key steps in the chain extension leading to the acid. The central issue of the synthesis was the merging of two chiral sectors (see A and B) to produce an ensemble in which the achiral spacer element consists of a single methylene carbon, C39. This problem was solved by establishing an ester bond between 5 and 6. The strategic C40-C39 carbon-carbon bond was generated by application of the Ireland ester enolate rearrangement. The extraneous carboxyl group (see structure 28) was removed by photolysis of the N-hydroxyphthalimide ester (see transformation 30 --> 31).

  DOI：

  10.1021/jo00020a026
• 作为产物：
  描述：

  (1R,2R,4S)-4-[(2R,3S,5S,6R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-7-hydroxy-2,6-dimethyl-heptyl]-2-methoxy-cyclohexanol 在 tris(triphenylphosphine)ruthenium(II) chloride 作用下， 以 苯 为溶剂， 反应 18.0h， 以73%的产率得到(2S,3S,5S,6R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-7-((1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-2,6-dimethyl-heptanal
  参考文献：
  名称：

  Synthetic studies toward rapamycin: a solution to a problem in chirality merger through use of the Ireland reaction

  摘要：

  A program directed toward a total synthesis of rapamycin is described. This paper reports the synthesis of enoate 36, a fragment that would correspond to carbons 28-49 of rapamycin. The two building blocks required to reach 36 were allylic alcohol 5 and acid 6. The former was obtained in a straightforward way from D-(+)-glucose. The route passed through a 5,6-methylene derivative (see structure 12) that underwent Ferrier transformation to the hydroxycyclohexanone derivative 13. The acid 6 was built from aldehyde 15. An addition reaction of allyltrimethylsilane to 15 and a subsequent addition of crotylboronate 18 to aldehyde 17 were the key steps in the chain extension leading to the acid. The central issue of the synthesis was the merging of two chiral sectors (see A and B) to produce an ensemble in which the achiral spacer element consists of a single methylene carbon, C39. This problem was solved by establishing an ester bond between 5 and 6. The strategic C40-C39 carbon-carbon bond was generated by application of the Ireland ester enolate rearrangement. The extraneous carboxyl group (see structure 28) was removed by photolysis of the N-hydroxyphthalimide ester (see transformation 30 --> 31).

  DOI：

  10.1021/jo00020a026